Perioperative bevacizumab-based triplet chemotherapy in patients with potentially resectable colorectal cancer liver metastases
Clinical Colorectal Cancer | Feb 04, 2019
Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer
Journal for ImmunoTherapy of Cancer | Feb 04, 2019
A multicenter, open-label, phase I study of nivolumab alone or in combination with gemcitabine plus cisplatin in patients with unresectable or recurrent biliary tract cancer
Journal of Clinical Oncology | Feb 03, 2019
A dose-finding study for irinotecan, cisplatin, and S-1 (IPS) in patients with advanced gastric cancer (OGSG 1106)
Journal of Clinical Oncology | Feb 03, 2019
A nationwide multicenter study in patients with unresectable hepatocellular carcinoma treated with lenvatinib in real world practice in Japan
Journal of Clinical Oncology | Feb 03, 2019
A phase I/Ib study of crenolanib with ramucirumab (RAM)/paclitaxel (PTX) as second-line therapy (2L tx) for advanced esophagogastric adenocarcinoma (EGA)
Journal of Clinical Oncology | Feb 03, 2019
A multicenter, phase Ib/2 study of varlitinib plus gemcitabine and cisplatin (gem/cis) for treatment of naïve, advanced, or metastatic biliary tract cancer (BTC).
Journal of Clinical Oncology | Feb 03, 2019
A variety of information related to Medicine and Health Care. It's all here.
